CORNELIUS, N.C., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Alpha Modus, Corp., a subsidiary of Alpha Modus Holdings Inc. (NASDAQ: AMOD) (“Alpha Modus” or the “Company”), today announced that it has filed a patent infringement lawsuit against Creative Realities, Inc. (“CRI”) in the United States District Court for the Eastern District of Texas, Marshall Division. The complaint asserts infringement of five of Alpha Modus’s foundational patents: U.S. Patent Nos. 10,360,571; 10,853,825; 10,977,672; 11,042,890; and 11, ...

Core Viewpoint - Hurco Companies, Inc. reported a net loss of $3.69 million for Q3 2025, an improvement from a net loss of $9.60 million in Q3 2024, indicating progress in financial performance despite ongoing challenges in the market [1][18]. Financial Performance - For Q3 2025, Hurco's sales and service fees reached $45.81 million, a 7% increase from $42.65 million in Q3 2024, aided by a favorable currency impact of $1.38 million [2][18]. - The gross profit for Q3 2025 was $9.11 million, representing 20% of sales, compared to $7.84 million or 18% of sales in the same quarter of the previous year [10][18]. - Selling, general, and administrative expenses for Q3 2025 were $10.76 million, or 23% of sales, down from 24% in Q3 2024, reflecting cost management efforts [11][12]. Geographic Sales Breakdown - Sales in the Americas increased by 10% to $16.90 million in Q3 2025, while sales in Europe remained flat at $24.17 million, and Asia Pacific saw a significant increase of 48% to $4.74 million [3][4][5]. - For the nine months of fiscal year 2025, total sales were $133.09 million, a slight increase of less than 1% compared to the same period in 2024 [2][3]. Orders and Demand - Total orders for Q3 2025 were $40.99 million, a decrease of 22% from $52.82 million in Q3 2024, with notable declines in orders from the Americas and Europe [6][7][8]. - Orders in the Americas decreased by 12% in Q3 2025, primarily due to reduced demand for Hurco and Milltronics machines [7][8]. Cash Position and Capital Allocation - As of July 31, 2025, cash and cash equivalents totaled $44.49 million, an increase from $33.33 million at the end of October 2024, indicating a strengthened cash position [14][18]. - The company has a share repurchase program with $19.68 million available for future repurchases, reflecting a commitment to returning value to shareholders [15][16]. Management Commentary - The CEO expressed optimism about the company's progress, highlighting improved gross profit and reduced operating costs, while acknowledging cautious capital purchase decisions due to macroeconomic uncertainty [3][16].

NEW YORK, NY, NEW HAVEN, CT, and PRINCETON, N.J., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Aptorum Group Limited (NASDAQ: APM) ("Aptorum Group” or “Aptorum”), a clinical stage biopharmaceutical company dedicated to addressing unmet medical needs, and DiamiR Biosciences Corp. (“DiamiR”), a developer of innovative blood-based diagnostic tests for brain health and other diseases, today announced a joint presentation at the H.C. Wainwright 27th Annual Global Investment Conference (https://hcwevents.com/annualconferen ...

Company Overview - FST Corp. is a leading manufacturer and marketer of steel and graphite golf shafts, providing various golf-related services [5] - Founded in 1989, the company sells golf club shafts and other items to golf equipment brands, OEMs, distributors, and consumers through KBS Golf Experience retail outlets [5] - The KBS brand is utilized by golfers at all levels, including many professional players in the PGA and other major golf associations [5] - FST Corp. has established a vertically integrated business model that creates significant competitive advantages over peer brands [5] - The company is currently positioned for expansion into the PRC and other under-tapped golf shaft markets [5] Event Participation - FST Corp. will participate in the 27th Annual H.C. Wainwright Global Investment Conference from September 8 to September 10, 2025 [1] - Sebastian Tadla, CFO, and Kathee Lin, Head of Investor Relations, will deliver a company presentation and be available for one-on-one investor meetings during the event [2] - The company's presentation is scheduled for September 8, 2025, from 2:30 PM to 3:00 PM in the Winslow Room, 5th Floor [8]

Core Points - Edgewell Personal Care Company announced the departure of Chief Operating Officer Dan Sullivan, effective October 1, 2025, to pursue another opportunity [1] - The company will not replace the COO role and will implement a regional hub structure to enhance efficiency and accountability [2] - CEO Rod Little emphasized the importance of Dan Sullivan's contributions and outlined plans to streamline operations and improve performance in North America [3] Company Overview - Edgewell is a leading consumer products company with a diversified portfolio of established brands, including Schick®, Wilkinson Sword®, Billie®, Playtex®, and Banana Boat® [4] - The company operates in over 50 markets globally, including the U.S., Canada, Mexico, Germany, Japan, the U.K., and Australia, employing approximately 6,700 people [4]

Core Insights - Avadel Pharmaceuticals presented new data on LUMRYZ, a once-nightly sodium oxybate treatment for narcolepsy, at World Sleep 2025, highlighting its efficacy in improving symptoms for both new and returning patients [1][2][3] Group 1: Efficacy of LUMRYZ - The REFRESH study demonstrated that patients switching from twice-nightly oxybate to LUMRYZ experienced clinically meaningful improvements in excessive daytime sleepiness (EDS) and other narcolepsy symptoms [4] - 70% of switch participants and 90% of non-switch participants reported improvement on the Patient Global Impression of Change after 4 months of therapy [4] - The study also indicated a reduction in severity of narcolepsy symptoms from moderate to mild, with significant improvements in quality of life metrics such as fatigue, brain fog, and mood [4] Group 2: Presentation Highlights - A total of 17 abstracts were accepted for presentation at World Sleep 2025, including one oral presentation and 16 posters, focusing on the benefits of LUMRYZ [1][2] - Presentations reinforced the advantages of LUMRYZ in addressing hallmark symptoms of narcolepsy, including EDS and sleep-related hallucinations [3] Group 3: Regulatory and Market Position - LUMRYZ is the first and only once-at-bedtime treatment for cataplexy or EDS in patients aged seven years and older with narcolepsy, receiving FDA approval in May 2023 and October 2024 [8][10] - The FDA granted LUMRYZ seven years of Orphan Drug Exclusivity due to its clinical superiority over existing treatments, emphasizing its once-nightly dosing regimen [10]

ROCKAWAY, N.J., Sept. 05, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today the departure of Peter Cuneo from the Board of Directors and that Thomas J. Errico, MD, has been elected to succeed Mr. Cuneo as Chairman of the Board, effective September 2, 2025. Mr. Cuneo will continue as a strategic advisor to the Company. “I want to offer my gratitude, and my congratulations to Peter Cuneo on his retirement from the electro ...

Midea MASTER Series Refrigerators Midea MASTER Series Refrigerators BERLIN, Sept. 05, 2025 (GLOBE NEWSWIRE) -- At Midea, we're committed to constantly innovating, elevating the performance of home appliances that enhance our everyday lives to be more efficient, effective and simply better. Therefore, we’re proud to showcase the latest in our lineup of home refrigerators across four product series here at IFA, with models featuring cutting-edge technologies including AI-powered cooling optimization and f ...

Core Insights - Firefly Neuroscience, Inc. has announced a partnership with HealingMaps and Advanced Behavioral Strategies to enhance access to its AI-driven brain health analytics platform for clinics specializing in ketamine and psychedelic-assisted therapies [1][2][5] - The collaboration follows the launch of the Healing Health Alliance, a Group Purchasing Organization aimed at supporting clinics in the psychedelic therapy space [2] - Firefly's platform utilizes non-invasive EEG assessments and AI to provide objective brain health analytics, addressing the limitations of traditional subjective assessments in neurological and mental health care [3][9] Company Overview - Firefly Neuroscience is an AI company focused on improving brain health outcomes through innovative solutions, with a proprietary database of over 180,000 EEG/ERP brain scans, making it the largest known repository of its kind [6] - The company's technology is FDA-510(k)-cleared and aims to revolutionize diagnostic and treatment monitoring for conditions such as depression, dementia, anxiety disorders, concussions, and ADHD [6] Benefits of the Partnership - The partnership allows clinics to access Firefly's objective brain health analytics, which can enhance treatment outcomes and create new revenue opportunities [5][9] - The platform provides measurable brain health changes correlated to treatments, improving patient confidence and engagement in their care [9]

Core Insights - Health In Tech has announced strategic leadership appointments to enhance AI utilization and accelerate growth [1][5] - The company is preparing to launch a next-generation AI Engine aimed at delivering real-time insights and automating decision-making [5] Leadership Appointments - Dustin Plantholt has been appointed as Chief Artificial Intelligence & Marketing Officer, focusing on AI strategy and marketing initiatives [2][4] - Zain Hasan joins as Head of Revenue and Growth, responsible for scaling national sales operations and enhancing partnerships [2][6] Strategic Importance of AI - The CEO, Tim Johnson, emphasized that AI is central to the company's future strategy, highlighting Plantholt's expertise in AI and growth leadership [3][4] - The upcoming AI Engine is seen as a foundational milestone in transforming the company into an indispensable ecosystem partner [5] Background of New Leaders - Plantholt has extensive experience in AI architecture and was recognized as Entrepreneur's Metaverse Advisor of the Year in 2022 [4][6] - Hasan has a strong track record in the benefits and insurance sector, having successfully led organizations through acquisitions and built national distribution networks [6][7]